global glp-1 obesity drug market size forecast 2030 Beyond GLP-1Rs: emerging targets poised to gain share of Competition will make weight-loss drugs

Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors

GLP-1 receptor agonists are useful, injectable drugs for the treatment of T2D as they improve glycemic control and atherosclerosis-related parameters [17-26]

While this study doesnt specifically look at eating disorders, it does suggest that people with eating disorders may be more likely to seek out GLP-1 medications

It is hypothesised that initiating a pharmacological intervention may be beneficial in overcoming motivational difficulties associated with lifestyle interventions

Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)

[Cut to Alexandra, a CVS Pharmacist, 8 years.] Alexandra, speaking: For diabetes, weve definitely seen the benefit that it can have in controlling blood sugar and your A1C